The Day Ahead newsletter:
The Morning News Call newsletter:
Wall Street was mixed in volatile trading on Friday after two days of heavy losses, as concerns of slowing global growth and the threat of a U.S. government shutdown weighed on investors' minds.
The top three S&P 500 percentage gainers:
** Nike Inc
** Carmax Inc
** Foot Locker Inc
The top S&P 500 percentage losers:
** Perrigo Co Plc, down 21.7 pct
** Conagra Brands Inc
The top three NYSE percentage gainers:
** Sunlands Online Education Group, up 17.3 pct
** Companhia Energetica de Minas Gerais
** Castlight Health Inc
The top three NYSE percentage losers:
** Perrigo Co Plc, down 21.7 pct
** Invesco S&P SmallCap Quality ETF
** Cambria Foreign Shareholder Yield ETF
The top three Nasdaq percentage gainers:
** Obalon Therapeutics Inc
** NF Energy Saving Corp
** BioHiTech Global Inc, up 20.5 pct
The top three Nasdaq percentage losers:
** Wheeler Real Estate Investment Trust Inc
** Wheeler Real Estate Investment Trust Inc
** Piedmont Lithium Ltd, down 20 pct
** Obalon Therapeutics Inc: up 45.1 pct
Surges on FDA approval of imaging technology
** Nike Inc: up 8.2 pct
Shares rally after Q2 results beat on strong N.America online sales
** Walgreens Boots Alliance Inc: down 1.2 pct
Street View: Int'l, wholesale businesses continue to be a drag on Walgreens
** Perrigo Company Plc: down 21.7 pct
Falls after $1.9 bln tax bill from Ireland authorities
** Accenture Plc: down 1.0 pct
Street View: Accenture's "solid" qtr overshadowed by weak forecast
** Altria Group Inc: down 2.0 pct
Gets first 'sell' ratings in over a year on "rich" Juul deal
** KKR & Co Inc: up 1.3 pct
Telepizza gains 30 pct in two days on KKR takeover bid
** Proteostasis Therapeutics Inc: down 3.0 pct
Falls as co delays reporting cystic fibrosis trial data
** TRACON Pharmaceuticals Inc: down 27.7 pct
Tumbles after cancer drug fails mid-stage trial
** CalAmp Corp: down 12.5 pct
CalAmp Corp: Analysts cut PT on supply chain, macro concerns
The 11 major S&P 500 sectors:
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.